A groundbreaking milestone has been reached in vaccine development: the first AI-designed vaccine has been tested in humans. As reported by Singularity Hub, scientists used artificial intelligence to identify targets shared by thousands of related viruses, aiming to create a universal vaccine. This marks a significant leap forward, showcasing AI's potential to revolutionize vaccine design. Traditional vaccines typically target a specific strain, but this AI-driven approach could provide broad protection against an entire virus family, including rapidly mutating ones like influenza. Early trial results are promising, but questions remain about the durability of immunity and effectiveness across diverse populations. Nevertheless, this development underscores AI's transformative role not just in tech, but in health and medicine. Scandinavian researchers are optimistic that AI-designed vaccines could become mainstream within the next decade, fundamentally altering pandemic preparedness. However, rigorous safety and long-term efficacy studies are still needed. This trial is a historic step, cementing AI's place in biotechnology and offering hope for faster, more adaptable vaccine responses in the future.